Physiological and pharmacological perspectives of melatonin

References

• Abadir, P.M., et al., 2006. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension (Dallas, Tex.: 1979), 48 (2), 316–322.
   PubMed Web of Science ®Google Scholar
• Acuña-Castroviejo, D., et al., 2014. Extrapineal melatonin: Sources, regulation, and potential functions. Cellular and molecular life sciences: Cmls, 71 (16), 2997–3025. doi:10.1007/s00018-014-1579-2
   PubMed Web of Science ®Google Scholar
• Adamczyk-Sowa, M., et al., 2014. Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients. Journal of physiology and pharmacology : an official journal of the Polish physiological society, 65 (4), 543–550.
   PubMed Web of Science ®Google Scholar
• Afeche, S. C., et al., 2008. Melatonin and the pineal gland. In: Romano E, De Luca S, eds. New research on neurosecretory systems. New York: Nova Biomedical Books, p. 151–177.
   Google Scholar
• Afroz, H., et al., 2015. Microscopic study on the shape of pineal calcification of Bangladeshi cadavers. Journal of Dhaka Medical College, 22 (2), 151–155.
   Google Scholar
• Agez, L., et al., 2007. Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience, 144 (2), 522–530.
   PubMed Web of Science ®Google Scholar
• Aleandri, V., Spina, V., and Morini, A., 1996. The pineal gland and reproduction. Human reproduction update, 2 (3), 225–235.
   PubMed Web of Science ®Google Scholar
• Alicelebić, S., et al., 2006. The role of pineal gland and exogenous melatonin on the irradiation stress response of suprarenal gland. Bosnian journal of basic medical sciences, 6 (4), 18–21.
   PubMedGoogle Scholar
• Alkozi, H.A., et al., 2018. Docking studies for melatonin receptors. Expert opinion on drug discovery, 13 (3), 241–248.
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine 2014. International classification of sleep disorders. 3rd ed. Darien (IL): American Academy of Sleep Medicine.
   Google Scholar
• Amihăesei, I.C., and Mungiu, O.C., 2012. Main neuroendocrine features and therapy in primary sleep troubles. Revista medico-chirurgicala a societatii de medici si naturalisti din iasi, 116 (3), 862–866.
   PubMedGoogle Scholar
• Anisimov, V.N., et al., 2000. Melatonin and colon carcinogenesis III. Effects of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Experimental and toxicologic pathology., 52 (1), 71–76.
   PubMedGoogle Scholar
• Arendt, J., and Skene, D.J., 2005. Melatonin as a chronobiotic. Sleep medicine reviews, 9 (1), 25–39.
   PubMed Web of Science ®Google Scholar
• Arendt, J., 2019. Melatonin: countering chaotic time cues. Frontiers in endocrinology, 10, 391.
   PubMed Web of Science ®Google Scholar
• Bahna, S.G., and Niles, L.P., 2018. Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. British journal of pharmacology, 175 (16), 3209–3219.
   PubMed Web of Science ®Google Scholar
• Bajova, H., Nelson, T.E., and Gruol, D.L., 2008. Chronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-kappaB in hippocampal neuronal cell culture. Journal of neuroimmunology, 195 (1-2), 36–46.
   PubMed Web of Science ®Google Scholar
• Bartlett, D.J., Biggs, S.N., and Armstrong, S.M., 2013. Circadian rhythm disorders among adolescents: assessment and treatment options. The medical journal of Australia, 199 (8), S16–S20.
   PubMed Web of Science ®Google Scholar
• Bartness, T.J., Demas, G.E., and Song, C.K., 2002. Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Experimental biology and medicine (Maywood, N.J.), 227 (6), 363–376.
   PubMed Web of Science ®Google Scholar
• Benaim, G., and Villalobo, A., 2002. Phosphorylation of calmodulin. Functional implications. European journal of biochemistry, 269 (15), 3619–3631.
   PubMedGoogle Scholar
• Benitez-King, G., 2006. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. Journal of pineal research, 40 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Benna, C., et al., 2017. Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis. Oncotarget, 8 (14), 23978–23995.
   PubMedGoogle Scholar
• Berga, S., et al., 1988. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. The journal of clinical endocrinology and metabolism, 66 (1), 242–244.
   PubMed Web of Science ®Google Scholar
• Bersani, G., et al., 1999. Computed tomography study of pineal calcification in schizophrenia. European psychiatry: The journal of the Association of European Psychiatrists, 14 (3), 163–166.
   PubMed Web of Science ®Google Scholar
• Bhat, S.A., et al., 2017. Synopsis on Managment strategies for neurodegenerative disorders: challenges from bench to bedside in successful drug discovery and development. Current topics in medicinal chemistry, 17 (12), 1371–1378.
   PubMed Web of Science ®Google Scholar
• Biran, V., et al., 2014. Is melatonin ready to be used in preterm infants as a neuroprotectant? Developmental medicine and child neurology, 56 (8), 717–723.
   PubMed Web of Science ®Google Scholar
• Bizzarri, M., et al., 2013. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert opinion on therapeutic targets, 17 (12), 1483–1496.
   PubMed Web of Science ®Google Scholar
• Bojkowski, C.J., et al., 1987. Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man. Hormone and metabolic research = hormon- und stoffwechselforschung = hormones et metabolisme, 19 (9), 437–440.
   PubMed Web of Science ®Google Scholar
• Bondy, S., and Campbell, A., 2018. Mechanisms underlying tumor suppressive properties of melatonin. International journal of molecular sciences, 19 (8), 2205.
   Web of Science ®Google Scholar
• Bonnefond, A., et al.,; The Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC). 2012. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nature genetics, 44 (3), 297–301..
   PubMed Web of Science ®Google Scholar
• Bouatia-Naji, N., et al., 2009. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nature genetics, 41 (1), 89–94.
   PubMed Web of Science ®Google Scholar
• Boutin, J.A., et al., 2008. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Archives of biochemistry and biophysics, 477 (1), 12–19.
   PubMed Web of Science ®Google Scholar
• Brainard, G.C., et al., 2001. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. The journal of neuroscience: the official journal of the society for neuroscience, 21 (16), 6405–6412.
   PubMed Web of Science ®Google Scholar
• Brown, R., et al., 1985. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. The American journal of psychiatry, 142 (7), 811–816.,
   PubMed Web of Science ®Google Scholar
• Brydon, L., et al., 2001. Functional expression of mt2 (mel1b) melatonin receptors in human paz6 adipocytes. Endocrinology, 142 (10), 4264–4271.
   PubMed Web of Science ®Google Scholar
• Brzezinski, A., 1997. Melatonin in humans. The New England journal of medicine, 336 (3), 186–195.
   PubMed Web of Science ®Google Scholar
• Bubenik, G.A., 2002. Gastrointestinal melatonin: localization, function, and clinical relevance. Digestive diseases and sciences, 47 (10), 2336–2348.
   PubMed Web of Science ®Google Scholar
• Buijs, R.M., et al., 2003. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. The journal of endocrinology, 177 (1), 17–26.
   PubMed Web of Science ®Google Scholar
• Bumb, J.M., et al., 2014. Pineal gland volume in primary insomnia and healthy controls: A magnetic resonance imaging study. Journal of sleep research, 23 (3), 276–282.
   Web of Science ®Google Scholar
• Burgess, H.J., Sharkey, K.M., and Eastman, C.I., 2002. Bright light, dark and melatonin can promote circadian adaptation in night shift workers. Sleep medicine reviews, 6 (5), 407–420.
   PubMed Web of Science ®Google Scholar
• Cardinali, D.P., et al., 1997. Melatonin site and mechanism of action: Single or multiple?. Journal of pineal research, 23 (1), 32–39.
   PubMed Web of Science ®Google Scholar
• Caroleo, M.C., et al., 1992. Melatonin as immunomodulatory in immunodeficient mice. Immunopharmacology, 23 (2), 81–89.
   PubMedGoogle Scholar
• Carrillo-Vico, A., et al., 2003. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its MT1 membrane receptor. FASEB journal: official publication of the federation of American societies for experimental biology, 17 (6), 755–757.
   PubMed Web of Science ®Google Scholar
• Carrillo-Vico, A., et al., 2005. A review of the multiple actions of melatonin on the immune system. Endocrine, 27 (2), 189–200.
   PubMed Web of Science ®Google Scholar
• Carrillo-Vico, A., et al., 2013. Melatonin: buffering the immune system. International journal of Molecular sciences, 14 (4), 8638–8683.
   PubMed Web of Science ®Google Scholar
• Castel, M., and Morris, J.F., 2000. Morphological heterogeneity of the GABAergic network in the suprachiasmatic nucleus, the brain’s circadian pacemaker. Journal of anatomy, 196 (1), 1–13.
   PubMedGoogle Scholar
• Cecon, E., et al., 2010. Daily variation of constitutively activated nuclear factor kappa B (NFKB) in rat pineal gland. Chronobiology international, 27 (1), 52–67.
   PubMed Web of Science ®Google Scholar
• Chakraborty, J., et al., 2014. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease. Behavioural brain research, 264, 91–104.
   PubMed Web of Science ®Google Scholar
• Chin, D., and Means, A.R., 2000. Calmodulin: a prototypical calcium sensor. Trends in cell biology, 10 (8), 322–328.
   PubMed Web of Science ®Google Scholar
• Chuang, J.I., Chen, S.S., and Lin, M.T., 1993. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology, 47 (2), 91–97.
   PubMed Web of Science ®Google Scholar
• Chuang, J.I., et al., 2016. Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment. Journal of pineal research, 61 (2), 230–240.
   PubMed Web of Science ®Google Scholar
• Claustrat, B., et al., 1984. A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression. Biological Psychiatry, 19, 1215–1228.
   PubMed Web of Science ®Google Scholar
• Comai, S., Ochoa-Sanchez, R., and Gobbi, G., 2013. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice . Behavioural brain research, 243, 231–238.
   PubMed Web of Science ®Google Scholar
• Cortese, S., et al., 2013. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. Journal of the American academy of child and adolescent psychiatry, 52 (8), 784–796.
   PubMed Web of Science ®Google Scholar
• Cortese, S., et al., 2006. ADHD and insomnia. Journal of the American academy of child and adolescent psychiatry, 45 (4), 384–385.
   PubMed Web of Science ®Google Scholar
• Costa, G., Haus, E., and Stevens, R., 2010. Shift work and cancer - considerations on rationale, mechanisms, and epidemiology. Scandinavian journal of work, environment and health, 36 (2), 163–179.
   PubMed Web of Science ®Google Scholar
• Dax, E.M., and Sugden, D., 1988. Age-associated changes in pineal adrenergic receptors and melatonin synthesizing enzymes in the Wistar rat. Journal of neurochemistry, 50 (2), 468–472.
   PubMed Web of Science ®Google Scholar
• de Borsetti, N.H., et al., 2011. Light and melatonin schedule neuronal differentiation in the habenular nuclei. Developmental biology, 358 (1), 251–261.
   PubMed Web of Science ®Google Scholar
• de Paula, R.M., et al., 2008. A connection between mapk pathways and circadian clocks. Cell cycle (Georgetown, Tex.).), 7 (17), 2630–2634.
   PubMed Web of Science ®Google Scholar
• Del Río, B., et al., 2004. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. The journal of biological chemistry, 279 (37), 38294–38302.
   PubMed Web of Science ®Google Scholar
• Den Boer, J.A., Bosker, F.J., and Meesters, Y., 2006. Clinical efficacy of agomelatine in depression: the evidence. International clinical psychopharmacology, 21 (1), S21–S24.
   PubMedGoogle Scholar
• Deng, Y.Q., et al., 2005. Effects of melatonin on wortmannin-induced tau hyperphosphorylation. Acta pharmacologica sinica, 26 (5), 519–526.
   PubMed Web of Science ®Google Scholar
• Ding, M., et al., 2018. Dynamin-related protein 1-mediated mitochondrial fission contributes to post-traumatic cardiac dysfunction in rats and the protective effect of melatonin. Journal of pineal research, 64 (1), e12447.
   Web of Science ®Google Scholar
• do Amaral, G.F., and Cipolla-Neto, J., 2018. A brief review about melatonin, a pineal hormone. Archives of endocrinology and metabolism, 62 (4), 472–479.
   PubMed Web of Science ®Google Scholar
• Do, M.T., and Yau, K.W., 2010. Intrinsically photosensitive retinal ganglion cells. Physiological reviews, 90 (4), 1547–1581.
   PubMed Web of Science ®Google Scholar
• Domínguez-Alonso, A., et al., 2015. Melatonin stimulates dendrite formation and complexity in the hilar zone of the rat hippocampus: participation of the Ca++/calmodulin complex. International journal of molecular sciences, 16 (1), 1907–1927. doi:10.3390/ijms16011907
   PubMed Web of Science ®Google Scholar
• Douglas-Hall, P., and Whicher, E.V., 2015. As required’ medication regimens for seriously mentally ill people ill people in hospital. Cochrane database of systematic review, 12, CD003441.
   Google Scholar
• Doyle, A.J., and Anderson, G.D., 2006. Physiologic calcification of the pineal gland in children on computed tomography: prevalence, observer reliability and association with choroid plexus calcification. Academic radiology, 13 (7), 822–826.
   PubMed Web of Science ®Google Scholar
• Drexler, J., 1963. The calcified pineal body and mammary carcinoma. Cancer, 16 (12), 1616–1617.
   PubMed Web of Science ®Google Scholar
• Dubocovich, M.L., et al., 2010. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacological reviews, 62 (3), 343–380.
   PubMed Web of Science ®Google Scholar
• Ebisawa, T., et al., 1994. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proceedings of the national academy of sciences of the United States of America, 91 (13), 6133–6137.
   PubMed Web of Science ®Google Scholar
• Ekmekcioglu, C., 2006. Melatonin receptors in humans: biological role and clinical relevance. Biomedicine and pharmacotherapy = biomedecine and pharmacotherapie, 60 (3), 97–108.
   PubMed Web of Science ®Google Scholar
• Ekstrom, P., and Meissl, H., 2003. Evolution of photosensory pineal organs in new light: the fate of neuroendocrine photoreceptors. Philosophical Transactions of the Royal Society of London. Series B, biological sciences, 358 (1438), 1679–1700.
   PubMed Web of Science ®Google Scholar
• Erdos, E.G., Tan, F., and Skidgel, R.A., 2010. Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension (Dallas, Tex.: 1979)), 55 (2), 214–220.
   PubMed Web of Science ®Google Scholar
• Erlich, S.S., and Apuzzo, M.L., 1985. The pineal gland: anatomy, physiology, and clinical significance. Journal of neurosurgery, 63 (3), 321–341.
   PubMed Web of Science ®Google Scholar
• Farhud, D., and Aryan, Z., 2018. Circadian rhythm, lifestyle and health: a narrative review. Iranian journal of public health, 47 (8), 1068–1076.
   PubMed Web of Science ®Google Scholar
• Farhud, D., and Tahavorgar, A., 2012. Melatonin hormone, metabolism and its clinical effects. Iranian journal of endocrinology and metabolism, 2, 211–223.
   Google Scholar
• Ferreira, Z.S., et al., 2005. Corticosterone modulates noradrenaline-induced melatonin synthesis through inhibition of nuclear factor kappa B. Journal of pineal research, 38 (3), 182–188.
   PubMed Web of Science ®Google Scholar
• Filipski, E., et al., 2004. Effects of chronic jet lag on tumor progression in mice. Cancer research, 64 (21), 7879–7885.
   PubMed Web of Science ®Google Scholar
• Fisher, S.P., and Sugden, D., 2010. Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle. Sleep, 33 (6), 833–840. doi:10.1093/sleep/33.6.833
   PubMed Web of Science ®Google Scholar
• Fjelldal, P.G., et al., 2004. Pinealectomy induces malformation of the spine and reduces the mechanical strength of the vertebrae in Atlantic salmon, Salmo salar. Journal of pineal research, 36 (2), 132–139.
   PubMed Web of Science ®Google Scholar
• Friedland, R.P., Luxenberg, J.S., and Koss, E., 1990. A quantitative study of intracranial calcification in dementia of the Alzheimer type. International psychogeriatrics, 2 (1), 36–43.
   PubMedGoogle Scholar
• Fu, L., and Lee, C.C., 2003. The circadian clock: pacemaker and tumour suppressor. Nature reviews cancer, 3 (5), 350–361.
   PubMed Web of Science ®Google Scholar
• Gallego, M., et al., 2006. An opposite role for tau in circadian rhythms revealed by mathematical modeling. Proceedings of the national academy of sciences of the United States of America, 103 (28), 10618–10623.
   PubMed Web of Science ®Google Scholar
• Geoffroy, P.A., et al.; membres du consensus Mélatonine SFRMS. 2019. The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS). L'Encephale, 45 (5), 413–423. doi:10.1016/j.encep.2019.04.068
   PubMed Web of Science ®Google Scholar
• Gheban, B.A., Rosca, I.A., and Crisan, M., 2019. The morphological and functional characteristics of the pineal gland. Medicine and pharmacy reports, 92 (3), 226–234.
   PubMedGoogle Scholar
• Gilad, E., et al., 1999. Melatonin receptors in PC3 human prostate tumor cells. Journal of pineal research, 26 (4), 211–220.
   PubMed Web of Science ®Google Scholar
• Golan, J., et al., 2002. Morphometric parameters of the human pineal gland in relation to age, body weight and height. Folia morphologica, 61 (2), 111–113.
   PubMedGoogle Scholar
• Goldman, S.E., et al., 2014. Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. Journal of autism and developmental disorders, 44 (10), 2525–2535.
   PubMed Web of Science ®Google Scholar
• Gomez-Gonzalez, B., et al., 2012. Role of sleep in the regulation of the immune system and the pituitary hormones. Annals of the New York academy of sciences, 1261, 97–106.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez, A., Mediavilla, M.D., and Sanchez-Barcelo, E.J., 2018. Melatonin: a molecule for reducing breast cancer risk. Molecules, 23, E336.
   PubMed Web of Science ®Google Scholar
• Gooley, J.J., et al., 2001. Melanopsin in cells of origin of the retinohypothalamic tract. Nature neuroscience, 4 (12), 1165
   PubMed Web of Science ®Google Scholar
• Grosshans, M., et al., 2016. The association of pineal gland volume and body mass in obese and normal weight individuals: A pilot study. Psychiatria danubina, 28 (3), 220–224.
   PubMed Web of Science ®Google Scholar
• Guermonprez, L., Ducrocq, C., and Gaudry-Talarmain, Y.M., 2001. Inhibition of acetylcholine synthesis and tyrosine nitration induced by peroxynitrite are differentially prevented by antioxidants. Molecular pharmacology, 60 (4), 838–846.
   PubMed Web of Science ®Google Scholar
• Gwinner, E., 1986. Circannual rhythms. Endogenous annual clocks in the organization of seasonal processes. Berlin: Springer,
   Google Scholar
• Hablitz, L.M., et al., 2015. GIRK channels mediate the nonphotic effects of exogenous melatonin. Journal of neuroscience, 35 (45), 14957–14965. doi:10.1523/JNEUROSCI.1597-15.2015
   PubMed Web of Science ®Google Scholar
• Hannibal, J., et al., 2004. Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. Investigative ophthalmology and visual science, 45 (11), 4202–4209.
   PubMed Web of Science ®Google Scholar
• Hansen, J., 2017. Night shift work and risk of breast cancer. Current environmental health reports, 4 (3), 325–339.
   PubMedGoogle Scholar
• Hansen, M.V., et al., 2014. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Breast cancer research and treatment, 145 (3), 683–695.
   PubMed Web of Science ®Google Scholar
• Hansen, M.V., et al., 2014. The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: a systematic review and meta-analysis. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 24 (11), 1719–1728.
   PubMed Web of Science ®Google Scholar
• Hastings, M.H., et al., 1985. Annual reproductive rhythms in mammals: Mechanisms of light synchronization. Annals of the New York academy of sciences, 453, 182–204.
   PubMed Web of Science ®Google Scholar
• Hattar, S., et al., 2003. Melanopsin and rod-cone photoreceptive systems account for all accessory major visual functions in mice. Nature, 424 (6944), 76–81.
   PubMed Web of Science ®Google Scholar
• He, H., Dong, W., and Huang, F., 2010. Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease. Current neuropharmacology, 8 (3), 211–217.
   PubMed Web of Science ®Google Scholar
• Henden, T., et al., 1992. Age-associated reduction in pineal beta-adrenergic receptor density is prevented by life-long food restriction in rats. Biological signals, 1 (1), 34–39.
   PubMedGoogle Scholar
• Herxheimer, A., and Petrie, K.J., 2002. Melatonin for preventing and treating jet lag. Cochrane database of systematic review, 2, CD001520. doi:10.1002/14651858.CD001520
   Google Scholar
• Hill, S.M., et al., 2015. Melatonin: an inhibitor of breast cancer. Endocrine-related cancer, 22 (3), R183–204.
   PubMed Web of Science ®Google Scholar
• Hill, S.M., et al., 1999. Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer. Advances in experimental medicine and biology, 460, 345–362.
   PubMed Web of Science ®Google Scholar
• Holvoet, E., and Gabriels, L., 2013. Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option? Tijdschr psychiatr, 55, 349–357.
   PubMedGoogle Scholar
• Hu, D.N., and Roberts, J.E., 1997. Melatonin inhibits growth of cultured human uveal melanoma cells. Melanoma research, 7 (1), 27–31.
   PubMed Web of Science ®Google Scholar
• Huang, S.H., Cao, X.J., and Wei, W., 2008. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages. Journal of pineal research, 45 (1), 93–100.
   PubMed Web of Science ®Google Scholar
• Ibañez Rodriguez, M.P., Noctor, S.C., and Muñoz, E.M., 2016. Cellular basis of pineal gland development: Emerging role of microglia as phenotype regulator. PLoS One, 11 (11), e0167063
   PubMed Web of Science ®Google Scholar
• Ivanov, I.I., et al., 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell, 126 (6), 1121–1133.
   PubMed Web of Science ®Google Scholar
• Iwasaki, S., et al., 2005. Melatonin as a local regulator of human placental function. Journal of pineal research, 39 (3), 261–265.
   PubMed Web of Science ®Google Scholar
• Jack, C.R., Jr., et al., 2010. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. The lancet. neurology, 9 (1), 119–128.
   PubMed Web of Science ®Google Scholar
• Jetten, A.M., 2009. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nuclear receptor signaling, 7, e003
   PubMedGoogle Scholar
• Jockers, R., et al., 2016. Update on melatonin receptors: IUPHAR Review 20. British journal of. pharmacology, 173 (18), 2702–2725.
   PubMed Web of Science ®Google Scholar
• Jockers, R., et al., 2008. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? British journal of pharmacology, 154 (6), 1182–1195.
   PubMed Web of Science ®Google Scholar
• Joseph, D., et al., 2015. Getting rhythm: how do babies do it? Archives of disease in childhood. fetal and neonatal edition, 100 (1), F50–F54.
   PubMed Web of Science ®Google Scholar
• Jung, K.H., et al., 2009. Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model. Journal of pineal research, 47 (2), 173–183.
   PubMed Web of Science ®Google Scholar
• Kalsbeek, A., Teclemariam-Mesbah, R., and Pévet, P., 1993. Efferent projections of the suprachiasmatic nucleus in the golden hamster (Mesocricetus auratus). The journal of comparative neurology, 332 (3), 293–314.
   PubMed Web of Science ®Google Scholar
• Kalsbeek, A., et al., 1996. A diurnal rhythm of stimulatory input to the hypothalamopituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. The journal of neuroscience : the official journal of the society for neuroscience, 16 (17), 5555–5565.
   PubMed Web of Science ®Google Scholar
• Kaminski, R.S.R., et al., 2015. Melatonin prevents hyperglycemia in a model of sleep apnea. Archives of endocrinology and metabolism, 59 (1), 66–70.
   PubMed Web of Science ®Google Scholar
• Kandalepas, P.C., Mitchell, J.W., and Gillette, M.U., 2016. Melatonin signal transduction pathways require e-box-mediated transcription of Per1 and Per2 to reset the SCN clock at dusk. Plos one, 11 (6), e0157824.
   PubMed Web of Science ®Google Scholar
• Karolczak, M., Korf, H.W., and Stehle, J.H., 2005. The rhythm and blues of gene expression in the rodent pineal gland. Endocrine, 27 (2), 89–100.
   PubMed Web of Science ®Google Scholar
• Kauppila, A., et al., 1987. Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. The journal of. clinical endocrinology and metabolism, 65 (5), 823–828.
   PubMed Web of Science ®Google Scholar
• Kennaway, D.J., 2000. Melatonin and development: physiology and pharmacology. Seminars in perinatology, 24 (4), 258–266.
   PubMed Web of Science ®Google Scholar
• Kennedy, S.H., et al., 1996. Nocturnal melatonin and 24-h 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry research, 63 (2-3), 219–222.
   PubMed Web of Science ®Google Scholar
• Kiefer, T., et al., 2002. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast cancer research and treatment, 71 (1), 37–45.
   PubMed Web of Science ®Google Scholar
• Kilic, E., et al., 2008. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. Journal of pineal research, 45 (2), 142–148.
   PubMed Web of Science ®Google Scholar
• Klein, D.C., Moore, R.Y., Reppert S.M., eds. 1991. Suprachiasmatic nucleus: The mind’s clock.New York: Oxford University Press. pp, 467.
   Google Scholar
• Klein, D.C., 2007. Arylalkylamine N-acetyltransferase: "the Timezyme". The journal of biological chemistry, 282 (7), 4233–4237.
   PubMed Web of Science ®Google Scholar
• Kondoh, T., et al., 2002. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life sciences, 72 (4-5), 583–590.
   PubMed Web of Science ®Google Scholar
• Kong, X., et al., 2008. Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cellular and molecular neurobiology, 28 (4), 569–579.
   PubMed Web of Science ®Google Scholar
• Konturek, S.J., et al., 2007. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). Journal of physiology and pharmacology: an official journal of the polish physiological society, 58 (3), 381–405.
   PubMed Web of Science ®Google Scholar
• Koshy, S., and Vettivel, S.K., 2001. Varying appearances of calcification in human pineal gland: a light microscopic study. Journla of the anatamical society of India, 50 (1), 17–18.
   Google Scholar
• Koyama, H., et al., 2002. Melatonin at pharmacologic doses increases bone mass by suppressing resorption throught downregulation of the RANKLmediated osteoclast formation and activation. Journal of bone and mineral research, 17 (7), 1219–1229.
   PubMed Web of Science ®Google Scholar
• Krakowski, G., and Cieciura, L., 1985. Ultrastructural studies on the pinealocyte mitochondria during the daytime and at night. Journal of pineal research, 2 (4), 315–324.
   PubMed Web of Science ®Google Scholar
• Kunz, D., et al., 1998. On pineal calcification and its relation to subjective sleep perception: a hypothesis-driven pilot study. Psychiatry research, 82 (3), 187–191.
   PubMed Web of Science ®Google Scholar
• Kus, I., et al., 2004. Light and electron microscopic examination of pineal gland in rats exposed to constant light and constant darkness. Neuro endocrinology letters, 25 (1-2), 102–108.
   PubMed Web of Science ®Google Scholar
• la Fleur, S.E., et al., 2001. Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. Journal of neuroendocrinology, 13 (12), 1025–1032.
   PubMed Web of Science ®Google Scholar
• Lahiri, D.K., et al., 2004. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. Journal of pineal research, 36 (4), 224–231.
   PubMed Web of Science ®Google Scholar
• Lahiri, D.K., 1999. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types. Journal of pineal research, 26 (3), 137–146.
   PubMed Web of Science ®Google Scholar
• Lai, M.C., Lombardo, M.V., and Baron-Cohen, S., 2014. Autism. Lancet (London, England), 383 (9920), 896–910.
   PubMed Web of Science ®Google Scholar
• Lambert HH. 1969. Response of the rat ovary to continuous light: effects of light frequency, intensity and duration of exposure. Doctoral Dissertations. 912. https://scholars.unh.edu/dissertation/912
   Google Scholar
• Lane, J.M., et al., 2016. Impact of common diabetes risk variant in MTNR1B on sleep, circadian, and melatonin physiology. Diabetes, 65 (6), 1741–1751.
   PubMed Web of Science ®Google Scholar
• Laudon, M., and Frydman-Marom, A., 2014. Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. International journal of molecular sciences, 15 (9), 15924–15950.
   PubMed Web of Science ®Google Scholar
• Lavie, P., 1997. Melatonin: Role in gating nocturnal rise in sleep propensity. Journal of biological rhythms, 12 (6), 657–665.
   PubMed Web of Science ®Google Scholar
• Lee, E.J., et al., 2005. Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia. Journal of pineal research, 38 (1), 42–52.
   PubMed Web of Science ®Google Scholar
• Lee, M.Y., et al., 2007. Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. Journal of pineal research, 42 (3), 297–309.
   PubMed Web of Science ®Google Scholar
• Leger, D., Laudon, M., and Zisapel, N., 2004. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. The American journal of medicine, 116 (2), 91–95.
   PubMed Web of Science ®Google Scholar
• Leja-Szpak, A., et al., 2010. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)). Journal of pineal research, 49 (3), 248–255.
   PubMed Web of Science ®Google Scholar
• Lerner, A.B., et al., 1958. Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. Journal of the American Chemical Society, 80 (10), 2587–2587.
   Web of Science ®Google Scholar
• Lewy, A.J., et al., 2006. The circadian basis of winter depression. Proceedings of the national academy of sciences of the United States of America, 103 (19), 7414–7419.
   PubMed Web of Science ®Google Scholar
• Lewy, A.J., et al., 1980. Light suppresses melatonin secretion in humans. Science (New York, N.Y.).), 210 (4475), 1267–1269.
   PubMed Web of Science ®Google Scholar
• Lewy, A.J., 2003. Clinical applications of melatonin in circadian disorders. Dialogues in clinical neuroscience, 5 (4), 399–413.
   PubMedGoogle Scholar
• Li, D.Y., et al., 2013. Melatonin receptor genes in vertebrates. International journal of molecular sciences, 14 (6), 11208–11223.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 1997. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron, 19 (1), 91–102.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2016. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annual review of pharmacology and toxicology, 56, 361–383.
   PubMed Web of Science ®Google Scholar
• Liu, L., Ying Xu, Y., and Reiter, R.J., 2013. Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63. Bone, 55 (2), 432–438.
   PubMed Web of Science ®Google Scholar
• López-González, A., et al., 2015. Melatonin treatment improves primary progressive multiple sclerosis: A case report. Journal of pineal research, 58 (2), 173–177.
   PubMed Web of Science ®Google Scholar
• Lotufo, C.M., Lopes, C., et al., 2001. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. European journal of pharmacology, 430 (2-3), 351–357.
   PubMed Web of Science ®Google Scholar
• Lotufo, C.M., et al., 2006. Melatonin effect on endothelial cells reduces vascular permeability increase induced by leukotriene B4. European journal of pharmacology, 534 (1-3), 258–263.
   PubMed Web of Science ®Google Scholar
• Luboshitzky, R., et al., 2000. Melatonin hypersecretion in male patients with adult-onset idiopathic hypogonadotropic hypogonadism. Experimental and Clinical Endocrinology & Diabetes : official Journal, German Society of Endocrinology [and] German Diabetes Association, 108 (2), 142–145.
   PubMed Web of Science ®Google Scholar
• Lyssenko, V., et al., 2009. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature genetics, 41 (1), 82–88.
   PubMed Web of Science ®Google Scholar
• Macchi, M.M., and Bruce, J.N., 2004. Human pineal physiology and functional significance of melatonin. Frontiers in neuroendocrinology, 25 (3-4), 177–195.
   PubMed Web of Science ®Google Scholar
• Macleod, M.R., et al., 2005. Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. Journal of pineal research, 38 (1), 35–41.
   PubMed Web of Science ®Google Scholar
• Marcola, M., et al., 2013. Endothelial cell adhesiveness is a function of environmental lighting and melatonin level. Journal of pineal research, 54 (2), 162–169.
   PubMed Web of Science ®Google Scholar
• Markus, R.P., Cecon, E., and Pires-Lapa, M.A., 2013. Immune-pineal axis: nuclear factor κB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells. International journal of molecular sciences, 14 (6), 10979–10997.
   PubMed Web of Science ®Google Scholar
• Markus, R.P., et al., 2018. Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. British journal of pharmacology, 175 (16), 3239–3250.
   PubMed Web of Science ®Google Scholar
• Markus, R.P., et al., 2007. The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation, 14 (3-4), 126–133.
   PubMed Web of Science ®Google Scholar
• Markus, R.P., and Ferreira, Z.S., 2011. The Immune-pineal axis: The role of pineal and extra-pineal melatonin in modulating inflammation. Advances in neuroimmune biology, 1 (1), 95–104.
   Google Scholar
• Masana, M.I., et al., 2002. MT(2) melatonin receptors are present and functional in rat caudal artery. The journal of pharmacology and experimental therapeutics, 302 (3), 1295–1302.
   PubMed Web of Science ®Google Scholar
• Matteo, S., 1987. The effect of job stress and job interdependency on menstrual cycle length, regularity and synchrony. Psychoneuroendocrinology, 12 (6), 467–476.
   PubMed Web of Science ®Google Scholar
• McArthur, A.J., Gillette, M.U., and Prosser, R.A., 1991. Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain research, 565 (1), 158–161.
   PubMed Web of Science ®Google Scholar
• McClintock, M.K., 1971. Menstrual synchorony and suppression. Nature, 229 (5282), 244–245.
   PubMed Web of Science ®Google Scholar
• Mediavilla, M.D., Cos, S., and Sánchez-Barceló, E.J., 1999. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life sciences, 65 (4), 415–420.
   PubMed Web of Science ®Google Scholar
• Migaud, M., et al., 2010. Emerging new sites for adult neurogenesis in the mammalian brain: a comparative study between the hypothalamus and the classical neurogenic zones. The European journal of neuroscience, 32 (12), 2042–2052.
   PubMed Web of Science ®Google Scholar
• Mohammadi, M.R., et al., 2012. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iranian journal of psychiatry, 7 (2), 87–92.
   PubMedGoogle Scholar
• Morera-Fumero, A.L., and Abreu-Gonzalez, P., 2013. Role of melatonin in schizophrenia. International journal of molecular sciences, 14 (5), 9037–9050.
   PubMed Web of Science ®Google Scholar
• Morgan, P., et al., 1994. Melatonin receptors: Localization, molecular pharmacology and physiological significance. Neurochemistry international, 24 (2), 101–146.
   PubMed Web of Science ®Google Scholar
• Muxel, S.M., et al., 2012. NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. Plos one, 7 (12), e52010.
   PubMed Web of Science ®Google Scholar
• Nagorny, C., and Lyssenko, V., 2012. Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story? Current diabetes reports, 12 (6), 667–672.
   PubMed Web of Science ®Google Scholar
• Nakade, O., et al., 1999. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. Journal of pineal research, 27 (2), 106–110.
   PubMed Web of Science ®Google Scholar
• Nichols, D.E., 2018. N,N-dimethyltryptamine and the pineal gland: Separating fact from myth. Journal of psychopharmacology (Oxford, England), 32 (1), 30–36.
   PubMed Web of Science ®Google Scholar
• Niles, L.P., et al., 2004. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC neuroscience, 5, 41
   PubMed Web of Science ®Google Scholar
• Nölte, I., et al., 2009. Pineal volume and circadian melatonin profile in healthy volunteers: an interdisciplinary approach. Journal of magnetic resonance imaging, 30 (3), 499–505.
   PubMed Web of Science ®Google Scholar
• Nordlund, J.J., and Lerner, A.B., 1977. The effects of oral melatonin on skin color and on the release of pituitary hormones. The journal of clinical endocrinology and. metabolism, 45 (4), 768–774.
   PubMed Web of Science ®Google Scholar
• Nosjean, O., et al., 2000. Identification of the melatonin-binding site MT3 as the quinone reductase 2. The journal of biological chemistry, 275 (40), 31311–31317.
   PubMed Web of Science ®Google Scholar
• O’Collins, V.E., et al., 2011. Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing. Journal of cerebral blood flow and metabolism : official journal of the international society of cerebral blood flow and metabolism, 31 (3), 962–975.
   PubMed Web of Science ®Google Scholar
• Obayashi, K., Saeki, K., and Kurumatani, N., 2014. Association between urinary 6-sulfatoxymelatonin excretion and arterial stiffness in the general elderly population: The HEIJO-KYO cohort. The journal of clinical endocrinology and metabolism, 99 (9), 3233–3239.
   PubMed Web of Science ®Google Scholar
• Ochoa-Sanchez, R., et al., 2011. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. The journal of neuroscience : the official journal of the society for neuroscience, 31 (50), 18439–18452.
   PubMed Web of Science ®Google Scholar
• Ochoa-Sanchez, R., et al., 2014. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states. Neuroscience letters, 561, 156–161.
   PubMed Web of Science ®Google Scholar
• Olie, P., and Emsley, R., 2005. Confirmed clinical efficacy of agomelatine (25-50 mg) in major depression; two randomized, double-blind controlled studies. European journal of neuropsychopharmacology, 15 (3), S416.
   Google Scholar
• Oren, M., 2003. Decision making by p53: Life, death and cancer. Cell death and differentiation, 10 (4), 431–442.
   PubMed Web of Science ®Google Scholar
• Ortiz, G.G., et al., 2017. Effect of melatonin administration on cyclooxygenase-2 activity, serum levels of nitric oxide metabolites, lipoperoxides and glutathione peroxidase activity in patients with Parkinson’s disease. Gaceta Medica de Mexico, 153 (Supl. 2), S72–S81.
   PubMedGoogle Scholar
• Ostrin, L.A., 2019. Ocular and systemic melatonin and the influence of light exposure. Clinical and experimental optometry, 102 (2), 99–108.
   PubMed Web of Science ®Google Scholar
• Owino, S., et al., 2016. Melatonin signaling controls the daily rhythm in blood glucose levels independent of peripheral clocks. Plos one, 11 (1), e0148214.
   PubMed Web of Science ®Google Scholar
• Pacchierotti, C., et al., 2001. Melatonin in Psychiatric Disorders: A Review on the Melatonin Involvement in Psychiatry. Frontiers in neuroendocrinology, 22 (1), 18–32. doi:10.1006/frne.2000.0202
   PubMed Web of Science ®Google Scholar
• Paltsev, M.A., et al., 2016. Morphofunctional and signaling molecules overlap of the pineal gland and thymus: Role and significance in aging. Oncotarget, 7 (11), 11972–11983.
   PubMedGoogle Scholar
• Pandi-Perumal, S.R., et al., 2006. Melatonin: Nature's most versatile biological signal? The FEBS journal, 273 (13), 2813–2838.
   PubMed Web of Science ®Google Scholar
• Parameyong, A., et al., 2013. Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells. Journal of pineal research, 55 (3), 313–323.
   PubMed Web of Science ®Google Scholar
• Pauley, S.M., 2004. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue. Medical hypotheses, 63 (4), 588–596.
   PubMed Web of Science ®Google Scholar
• Pei, Z., Pang, S.F., and Cheung, R.T., 2003. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke, 34 (3), 770–775.
   PubMed Web of Science ®Google Scholar
• Petranka, J., et al., 1999. The oncostatic action of melatonin in an ovarian carcinoma cell line. Journal of pineal research, 26 (3), 129–136.
   PubMed Web of Science ®Google Scholar
• Pierpaoli, W., and Regelson, W., 1994. Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proceedings of the national academy of sciences of the United States of America, 91 (2), 787–791.
   PubMed Web of Science ®Google Scholar
• Pires-Lapa, M.A., et al., 2013. Melatonin synthesis in human colostrum mononuclear cells enhances dectin-1-mediated phagocytosis by mononuclear cells. Journal of pineal research, 55 (3), 240–246.
   PubMed Web of Science ®Google Scholar
• Plant, T.M., and Zorub, D.S., 1986. Pinealectomy in agonadal infantile male rhesus monkeys (Macaca mulatta) does not interrupt initiation of the prepubertal hiatus in gonadotropin secretion. Endocrinology, 118 (1), 227–232.
   PubMed Web of Science ®Google Scholar
• Pontes, G.N., et al., 2006. Injury switches melatonin production source from endocrine (pineal) to paracrine (phagocytes) - melatonin in human colostrum and colostrum phagocytes. Journal of pineal research, 41 (2), 136–141.
   PubMed Web of Science ®Google Scholar
• Porfirio, M.C., et al., 2017. Can melatonin prevent or improve metabolic side effects during antipsychotic treatments? Neuropsychiatric disease and treatment, 13, 2167–2174.
   PubMed Web of Science ®Google Scholar
• Potter, G.D.M., et al., 2016. Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures. Endocrine reviews, 37 (6), 584–608.
   PubMed Web of Science ®Google Scholar
• Pu, Y., et al., 2007. High prevalence of pineal cysts in healthy adults demonstrated by high-resolution, noncontrast brain MR imaging. American journal of neuroradiology, 28 (9), 1706–1709.
   PubMed Web of Science ®Google Scholar
• Puig-Domingo, M., et al., 1992. Brief report: melatonin-related hypogonadotropic hypogonadism. The New England journal of medicine, 327 (19), 1356–1359.
   PubMed Web of Science ®Google Scholar
• Quay, W.B., 1970. Precocious entrainment and associated characteristics of activity patterns following pinalectomy and reversal of photoperiod. Physiology and behavior, 5 (11), 1281–1290.
   PubMed Web of Science ®Google Scholar
• Radogna, F., Diederich, M., and Ghibelli, L., 2010. Melatonin: a pleiotropic molecule regulating inflammation. Biochemical pharmacology, 80 (12), 1844–1852.
   PubMed Web of Science ®Google Scholar
• Ramirez-Rodriguez, G., et al., 2009. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology : official Publication of the American College of Neuropsychopharmacology, 34 (9), 2180–2191.
   PubMed Web of Science ®Google Scholar
• Ramirez-Rodriguez, G., et al., 2011. Chronic treatment with melatonin stimulates dendrite maturation and complexity in adult hippocampal neurogenesis of mice. Journal of pineal research, 50 (1), 29–37.
   PubMed Web of Science ®Google Scholar
• Ramirez-Rodriguez, G.B., et al., 2018. Melatonin influences structural plasticity in the axons of granule cells in the dentate gyrus of Balb/C mice. International journal of molecular sciences, 20 (1), 73.
   Web of Science ®Google Scholar
• Rasmussen, D.D., et al., 1999. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology, 140 (2), 1009–1012.
   PubMed Web of Science ®Google Scholar
• Rawashdeh, O., et al., 2007. Melatonin suppresses nighttime memory formation in zebrafish. Science (New York, N.Y.).), 318 (5853), 1144–1146.
   PubMed Web of Science ®Google Scholar
• Rawashdeh, O., and Maronde, E., 2012. The hormonal Zeitgeber melatonin: Role as a circadian modulator in memory processing. Frontiers in molecular neuroscience, 5, 27.
   PubMed Web of Science ®Google Scholar
• Reiter, R.J., et al., 1999. Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mechanisms of ageing and development, 110 (3), 157–173.
   PubMed Web of Science ®Google Scholar
• Reiter, R.J., Tan, D.X., and Galano, A., 2014. Melatonin: exceeding expectations. Physiology (Bethesda, Md.).), 29 (5), 325–333.
   PubMed Web of Science ®Google Scholar
• Reiter, R.J., et al., 2007. Medical implications of melatonin: receptor-mediated and receptorindependent actions. Advances in medical science, 52, 11–28.
   PubMed Web of Science ®Google Scholar
• Reiter, R.J., 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine reviews, 12 (2), 151–180.
   PubMed Web of Science ®Google Scholar
• Reiter, R.J., 1993. The melatonin rhythm: both a clock and a calendar. Experientia, 49 (8), 654–859.
   PubMedGoogle Scholar
• Reiter, R.J., 1998. Cytoprotective properties of melatonin: presumed association with oxidative damage and aging. Nutrition (Burbank, Los Angeles County, Calif.).), 14 (9), 691–696.
   PubMed Web of Science ®Google Scholar
• Reppert, S.M., et al., 1995. Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor. Proceedings of the national academy of sciences of the United States of America, 92 (19), 8734–8738.
   PubMed Web of Science ®Google Scholar
• Reppert, S.M., and Weaver, D.R., 2001. Molecular analysis of mammalian circadian rhythms. Annual review of physiology, 63, 647–676.
   PubMed Web of Science ®Google Scholar
• Revell, V.L., et al., 2006. Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light. Journal of clinical endocrinology and metabolism, 91 (1), 54–59.
   PubMed Web of Science ®Google Scholar
• Reybier, K., et al., 2011. Insights into the redox cycle of human quinone reductase 2. Free radical research, 45 (10), 1184–1195.
   PubMed Web of Science ®Google Scholar
• Rojansky, N., Brzezinski, A., and Schenker, J.G., 1992. Seasonality in human reproduction: an update. Human reproduction (Oxford, England)), 7 (6), 735–745.
   PubMed Web of Science ®Google Scholar
• Rojczyk-Gołębiewska, E., Pałasz, A., and Wiaderkiewicz, R., 2014. Hypothalamic subependymal niche: a novel site of the adult neurogenesis. Cellular and molecular neurobiology, 34 (5), 631–642.
   PubMed Web of Science ®Google Scholar
• Rosales-Corral, S., et al., 2003. Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. Journal of pineal research, 35 (2), 80–84.
   PubMed Web of Science ®Google Scholar
• Rosales-Corral, S.A., et al., 2012. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. Journal of pineal research, 52 (2), 167–202.
   PubMed Web of Science ®Google Scholar
• Roskoski, R., Jr. 2016. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs. Pharmacological research, 107, 249–275.
   PubMed Web of Science ®Google Scholar
• Roth, J.A., et al., 1999. Melatonin promotes osteoblast differentiation and bone formation. The journal of biological chemistry, 274 (31), 22041–22047.
   PubMed Web of Science ®Google Scholar
• Roy, D., and Belsham, D.D., 2002. Melatonin receptor activation regulates GnRH gene expression and secretion in GT1-7 GnRH neurons. Signal transduction mechanisms. The journal of biological chemistry, 277 (1), 251–258.
   PubMed Web of Science ®Google Scholar
• Sabatini, R.A., et al., 2008. ACE activity is modulated by kinin B2 receptor. Hypertension (Dallas, Tex. : 1979)), 51 (3), 689–695.
   PubMed Web of Science ®Google Scholar
• Sack, R.L., et al.,; American Academy of Sleep Medicine. 2007. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep, 30 (11), 1484–1501.
   PubMed Web of Science ®Google Scholar
• Sadat-Ali, M., Habdan, I., and Othman, A., 2000. Adolescent idiopathic scoliosis. Is low melatonin a cause?. Joint bone spine, 67, 62–64.
   PubMed Web of Science ®Google Scholar
• Sadeh, A., 1997. Sleep and melatonin in infants: a preliminary study. Sleep, 20 (3), 185–191.
   PubMed Web of Science ®Google Scholar
• Samuel, D.S., Duraisamy R., and Kumar, M., 2018. Pineal gland - A mystic gland. Drug invention today, 11 (1), 55–58.
   Google Scholar
• Sanchez-Barcelo, E.J., et al., 2017. Clinical uses of melatonin in neurological diseases and mental and behavioural disorders. Current medicinal chemistry, 24 (35), 3851–3878.
   PubMed Web of Science ®Google Scholar
• Santoro, R., et al., 2012. Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation. Oncogene, 31 (24), 2931–2942.
   PubMed Web of Science ®Google Scholar
• Sapède, D., and Cau, E., 2013. The pineal gland from development to function. Current topics in developmental biology, 106, 171–215. doi:10.1016/B978-0-12-416021-7.00005-5
   PubMed Web of Science ®Google Scholar
• Saper, C.B., et al., 2005. The hypothalamic integrator for circadian rhythms. Trends in neurosciences, 28 (3), 152–157.
   PubMed Web of Science ®Google Scholar
• Saxvig, I.W., et al., 2014. A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: effects on subjective and objective sleep. Chronobiology international, 31 (1), 72–86.
   PubMed Web of Science ®Google Scholar
• Scheer, F.A., et al., 2012. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep, 35 (10), 1395–1402.
   PubMed Web of Science ®Google Scholar
• Scheer, F.A., et al., 2004. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension (Dallas, Tex.: 1979)), 43 (2), 192–197.
   PubMed Web of Science ®Google Scholar
• Scheer, F.A., 2005. Potential use of melatonin as adjunct antihypertensive therapy. American journal of hypertension, 18 (12 Pt 1), 1619–1620.
   PubMed Web of Science ®Google Scholar
• Schernhammer, E.S., et al., 2003. Night-shift work and risk of colorectal cancer in the nurses' health study. Journal of the National Cancer Institute, 95 (11), 825–828.
   PubMedGoogle Scholar
• Sharma, V.K., and Chandrashekaran, M.K., 2005. Zeitgebers (time cues) for biological clocks. Current science, 89 (7), 1136–1146.
   Web of Science ®Google Scholar
• Shechter, A., et al., 2012. Nocturnal polysomnographic sleep across the menstrual cycle in premenstrual dysphoric disorder. Sleep medicine, 13 (8), 1071–1078.
   PubMed Web of Science ®Google Scholar
• Silman, R., 1991. Melatonin and the human gonadotrophin-releasing hormone pulse generator. The journal of endocrinology, 128 (1), 7–11.
   PubMed Web of Science ®Google Scholar
• Silva, S.O., et al., 2004. Neutrophils as a specific target for melatonin and kynuramines: Effects on cytokine release. Journal of neuroimmunology, 156 (1-2), 146–152.
   PubMed Web of Science ®Google Scholar
• Sinha, B.R., et al., 2014. A comparative study indicates methimazole induced chemical hypothyroidism causes inhibition of pineal gland karyomorphology in three different species of animals. International journal of pure and applied zoology, 2, 84–94.
   Google Scholar
• Skwarlo-Sonta, K., et al., 2003. Bidirectional communication between the pineal gland and the immune system. Canadian journal of physiology and pharmacology, 81 (4), 342–349.
   PubMed Web of Science ®Google Scholar
• Slawik, H., et al., 2016. Prospective Study on Salivary Evening Melatonin and Sleep before and after Pinealectomy in Humans. Journal of biological rhythms, 31 (1), 82–93.
   PubMed Web of Science ®Google Scholar
• Sletten, T.L., et al.,; for the Delayed Sleep on Melatonin (DelSoM) Study Group. 2018. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLOS Medicine, 15 (6), e1002587.
   PubMed Web of Science ®Google Scholar
• Smith, J.A., O'Hara, J., and Schiff, A.A., 1981. Altered diurnal serum melatonin rhythm in blind men. Lancet (London, England), 2 (8252), 933.
   PubMed Web of Science ®Google Scholar
• Smith, M.R., Fogg, L.F., and Eastman, C.I., 2009. Practical interventions to promote circadian adaptation to permanent night shift work: study 4. Journal of biological rhythms, 24 (2), 161–172.
   PubMed Web of Science ®Google Scholar
• Song, J., 2019. Pineal gland dysfunction in Alzheimer's disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis. Molecular neurodegeneration, 14 (1), 28
   PubMedGoogle Scholar
• Soto-Vega, E., et al., 2004. Melatonin stimulates calmodulin phosphorylation by protein kinase C. Journal of pineal research, 37 (2), 98–106. doi:10.1111/j.1600-079X.2004.00141.x
   PubMed Web of Science ®Google Scholar
• Spitzer, R.L., et al., 1999. Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial. American journal of psychiatry, 156, 1392–1396.
   PubMed Web of Science ®Google Scholar
• Srinivasan, V., et al., 2010. Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value. International journal of Alzheimer's disease, 2011, 741974
   PubMedGoogle Scholar
• Srinivasan, V., et al., 2005. Role of melatonin in neurodegenerative diseases. Neurotoxicity research, 7 (4), 293–318.
   PubMed Web of Science ®Google Scholar
• Srinivasan, V., et al., 2006. Melatonin in mood disorders. World journal of biological psychiatry, 7 (3), 138–151.
   PubMed Web of Science ®Google Scholar
• Stevens, R. G., 2004. Epidemiological evidence on artificial lighting patterns and risk of breast cancer. Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute.
   Google Scholar
• Straif, K., et al.,; WHO International Agency For Research on Cancer Monograph Working Group. 2007. Carcinogenicity of shift-work, painting, and fire-fighting. The lancet oncology, 8 (12), 1065–1066.
   PubMed Web of Science ®Google Scholar
• Su, S.C., et al., 2017. Cancer metastasis: mechanisms of inhibition by melatonin. Journal of pineal research, 62, 12370.
   Web of Science ®Google Scholar
• Sun, X., et al., 2016. The potential role of melatonin on mental disorders: insights from physiology and pharmacology. Bipolar disorder: open access, 2 (1). doi:10.4172/2472-1077.1000105
   Google Scholar
• Suofu, Y., et al., 2017. Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proceedings of the national academy of sciences of the United States of America, 114 (38), E7997–E8006. doi:10.1073/pnas.1705768114
   PubMed Web of Science ®Google Scholar
• Tamarkin, L., et al., 1981. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer research, 41 (11 Pt 1), 4432–4436.
   PubMed Web of Science ®Google Scholar
• Tamura, E.K., Silva, C.L., and Markus, R.P., 2006. Melatonin inhibits endothelial nitric oxide production in vitro. Journal of pineal research, 41 (3), 267–274.
   PubMed Web of Science ®Google Scholar
• Tan, D.X., et al., 2016. Melatonin: A mitochondrial targeting molecule involving mitochondrial protection and dynamics. International journal of molecular sciences, 17 (12), 2124.
   Web of Science ®Google Scholar
• Tan, D.X., et al., 2007. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. Journal of pineal research, 42 (1), 28–42.
   PubMed Web of Science ®Google Scholar
• Tan, D.X., et al., 2018. Pineal calcification, melatonin production, aging, associated health consequences and rejuvenation of the pineal gland. Molecules, 23 (2), 301. pii:
   PubMed Web of Science ®Google Scholar
• Tapp, E., 1979. The histology and pathology of the human pineal gland. Progress in brain research, 52, 481–500.
   PubMedGoogle Scholar
• Tchekalarova, J., et al., 2016. Consequences of long-term treatment with agomelatine on depressive-like behavior and neurobiological abnormalities in pinealectomized rats. Behavioural brain research, 302, 11–28.
   PubMed Web of Science ®Google Scholar
• Tocharus, C., et al., 2014. Melatonin enhances adult rat hippocampal progenitor cell proliferation via ERK signaling pathway through melatonin receptor. Neuroscience, 275, 314–321.
   PubMed Web of Science ®Google Scholar
• Toh, K.L., 2008. Basic science review on circadian rhythm biology and circadian sleep disorders. Annual academic medicine (Singapore), 37 (8), 662–668.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., et al., 2005. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biological psychiatry, 57 (2), 134–138.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., et al., 2017. Melatonin: pharmacology, functions and therapeutic benefits. Current neuropharmacology, 15 (3), 434–443.
   PubMed Web of Science ®Google Scholar
• Tordjman, S., et al., 2013. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. International journal of molecular sciences, 14 (10), 20508–20542.
   PubMed Web of Science ®Google Scholar
• Tuomi, T., et al., 2016. Increased melatonin signaling is a risk factor for type 2 diabetes. Cell metabolism, 23 (6), 1067–1077.
   PubMed Web of Science ®Google Scholar
• Turgut, A.T., et al., 2008. Age-related changes in the incidence of pineal gland calcification in Turkey: A prospective multicenter CT study. Pathophysiology, 15 (1), 41–48.
   PubMedGoogle Scholar
• Unger, T., et al., 1999. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. The EMBO journal, 18 (7), 1805–1814.
   PubMed Web of Science ®Google Scholar
• Van Geijlswijk, I.M., Korzilius, H., and Smits, M.G., 2010. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep, 33 (12), 1605–1614.
   PubMed Web of Science ®Google Scholar
• Vandewalle, G., et al., 2007. Robust circadian rhythm in heart rate and its variability: influence of exogenous melatonin and photoperiod. Journal of sleep research, 16 (2), 148–155.
   PubMed Web of Science ®Google Scholar
• Varma, A., et al., 2002. The effect of antidepressants on serum melatonin levels in endogenous depression. Journal of association of physicians India, 50, 1262–1265.
   PubMedGoogle Scholar
• Vinogradova, I.A., et al., 2010. Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in young but not in old rats. Aging, 2 (2), 82–92.
   PubMedGoogle Scholar
• Voordouw, B.C., et al., 1992. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. The journal of clinical endocrinology and metabolism, 74 (1), 108–117.
   PubMed Web of Science ®Google Scholar
• Waly, N.E., and Hallworth, R., 2015. Circadian pattern of melatonin MT1 and MT2 receptor localization in the rat suprachiasmatic nucleus. Journal of circadian rhythms, 13, 1–7.
   PubMedGoogle Scholar
• Wang, X.C., et al., 2008. Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells. Neurochemical research, 33 (6), 1138–1144.
   PubMed Web of Science ®Google Scholar
• Wei, J.Y., et al., 2015. Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation. Journal of pineal research, 58 (4), 429–438.
   PubMed Web of Science ®Google Scholar
• Weishaupt, J.H., et al., 2006. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of pineal research, 41 (4), 313–323.
   PubMed Web of Science ®Google Scholar
• Welsh, D.K., Takahashi, J.S., and Kay, S.A., 2010. Suprachiasmatic nucleus: cell autonomy and network properties. Annual review of physiology, 72, 551–577.
   PubMed Web of Science ®Google Scholar
• Westermann, J., et al., 2015. System consolidation during sleep - a common principle underlying psychological and immunological memory formation. Trends in neurosciences, 38 (10), 585–597.
   PubMed Web of Science ®Google Scholar
• Wideman, C.H., and Murphy, H.M., 2009. Constant light induces alterations in melatonin levels, food intake, feed efficiency, visceral adiposity, and circadian rhythms in rats. Nutritional neuroscience, 12 (5), 233–240.
   PubMed Web of Science ®Google Scholar
• Wilson, H.C., Kiefhaber, S.H., and Gravel, V., 1991. Two studies of menstrual synchrony: negative results. Psychoneuroendocrinology, 16 (4), 353–359.
   PubMed Web of Science ®Google Scholar
• Witt-Enderby, P.A., et al., 2000. Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin-receptor. Cell motility and the cytoskeleton, 46 (1), 28–42.
   PubMed Web of Science ®Google Scholar
• Wu, J.-H., et al., 2016. Effect of melatonin and calmodulin in an Idiopathic Scoliosis Model. BioMed research international, 2016, 8460291. doi:10.1155/2016/8460291
   PubMed Web of Science ®Google Scholar
• Xie, S., et al., 2015. Melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy by modulating autophagy through the 5' adenosine monophosphate-activated protein kinase pathway. Biochemical and Biophysical Research Communication, 464 (4), 975–981.
   PubMed Web of Science ®Google Scholar
• Xie, Z., et al., 2017. A review of sleep disorders and melatonin. Neurological research, 39 (6), 559–565.
   PubMed Web of Science ®Google Scholar
• Yang, Y., et al., 2017. Up-regulation of miR-325-3p suppresses pineal aralkylamine N-acetyltransferase (Aanat) after neonatal hypoxia-ischemia brain injury in rats . Brain Research, 1668, 28–35.
   PubMed Web of Science ®Google Scholar
• Yeung, H.M., et al., 2015. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. Journal of pineal research, 58 (1), 12–25.
   PubMed Web of Science ®Google Scholar
• Zacharias, L., and Wurtman, R.J., 1964. Blindness: its relation to age of menarche. Science (New York, N.Y.)), 144 (3622), 1154–1155.
   PubMedGoogle Scholar
• Zawilska, J.B., Skene, D.J., and Arendt, J., 2009. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacological reports, 61 (3), 383–410.
   PubMed Web of Science ®Google Scholar
• Zee, P.C., and Goldstein, C.A., 2010. Treatment of shift work disorder and jet lag. Current treatment options in neurology, 12 (5), 396–411.
   PubMed Web of Science ®Google Scholar
• Zeitzer, J.M., et al., 2000. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. The journal of physiology, 526 (3), 695–702.
   PubMed Web of Science ®Google Scholar
• Zhang, W., et al., 2016. Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials. Neurological sciences : official journal of the Italian neurological society and of the Italian society of clinical neurophysiology, 37 (1), 57–65.
   PubMed Web of Science ®Google Scholar
• Zhao, D., et al., 2019. Melatonin synthesis and function: evolutionary history in animals and plants. Frontiers in endocrinology, 10, 249.
   PubMed Web of Science ®Google Scholar
• Zhdanova, I., Lynch, H., and Wurtman, R., 1997. Melatonin: a sleeppromoting hormone. Sleep, 20, 899–907.
   PubMed Web of Science ®Google Scholar
• Zhdanova, I.V., et al., 1995. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clinical pharmacology therapy, 57 (5), 552–558.
   PubMed Web of Science ®Google Scholar
• Zhou, J.N., et al., 2003. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. Journal of pineal research, 35 (2), 125–130.
   PubMed Web of Science ®Google Scholar